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Abstract
We applied our method of pairwise shared genomic segment (pSGS) analysis to high-risk pedigrees identified from
the Genetic Analysis Workshop 17 (GAW17) mini-exome sequencing data set. The original shared genomic
segment method focused on identifying regions shared by all case subjects in a pedigree; thus it can be sensitive
to sporadic cases. Our new method examines sharing among all pairs of case subjects in a high-risk pedigree and
then uses the mean sharing as the test statistic; in addition, the significance is assessed empirically based on the
pedigree structure and linkage disequilibrium pattern of the single-nucleotide polymorphisms. Using all GAW17
replicates, we identified 18 unilineal high-risk pedigrees that contained excess disease (p < 0.01) and at least 15
meioses between case subjects. Eighteen rare causal variants were polymorphic in this set of pedigrees. Based on a
significance threshold of 0.001, 72.2% (13/18) of these pedigrees were successfully identified with at least one
region that contains a true causal variant. The regions identified included 4 of the possible 18 polymorphic causal
variants. On average, 1.1 true positives and 1.7 false positives were identified per pedigree. In conclusion, we have
demonstrated the potential of our new pSGS method for localizing rare disease causal variants in common disease
using high-risk pedigrees and exome sequence data.
Background
The original shared genomic segment (SGS) method is an
analytical technique designed specifically for finding rare
disease variants in high-risk extended pedigrees [1,2]. It
was designed for use with dense single-nucleotide poly-
morphism (SNP) genotyping to identify regions of identi-
cal-by-state (IBS) sharing between multiple distantly
related case subjects. Identical-by-descent (IBD) sharing
between distant relatives is increasingly improbable with
genetic distance and is expected to be short. Regions IBD
must also be IBS. IBS sharing is much simpler to identify,
and long lengths of IBS sharing that are not expected by
chance are likely to be shared IBD. Therefore the identifi-
cation of long, shared IBS regions among distant case sub-
jects in a family may identify the area that is also shared
IBD; this IBD area contains genes that predispose the indi-
vidual to a given disease trait.
For rare diseases (≤ 1% frequency in the population)
with rare causal variants (minor allele frequency [MAF]
≤ 0.005), the original SGS method based on sharing
among all case subjects in high-risk pedigrees has good
power, even under moderate penetrance. Under these
scenarios, the likelihood of intrafamilial heterogeneity is
decreased and hence the likelihood that all case subjects
share the same causal variant is increased. However, for
more common diseases, where not all case subjects may
be affected by the same underlying causal variants, an
SGS method based on sharing of all case subjects may
lack power. Instead, examining sharing among all pairs
of case subjects would increase the robustness of the
method.
In this study, we develop a new pairwise SGS method
that examines the sharing among all pairs of case subjects.
We apply the pairwise SGS (pSGS) method to a set of 18
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17 (GAW17) data set. The known population disease
prevalence rate for the simulated disease is about 30%.
Methods
Each replicate of the GAW17 family data set consists of
eight different pedigree structures, each with four genera-
tions. We split the pedigrees into unilineal lines of descent,
which include two common ancestral founders along with
their descendants. We use all 200 replicates and identify
high-risk pedigrees, defined as those with at least 15 total
meioses between case subjects and a statistical excess of
disease (p < 0.01). We selected the threshold of at least 15
meioses because the genome-wide probability of IBD shar-
ing by chance across 15 meioses is approximately 0.05 [1].
Eighteen pedigrees meet the criteria of 15 total meioses
and excess disease. All these pedigrees are derived from
GAW17 pedigree structure 7, which was based on a unili-
neal descendants from founders 7010 and 7013. This pedi-
gree structure contains 59 individuals, with 16 founders
and 43 related descendants (Figure 1). Although the struc-
ture is consistent, each of the 18 pedigrees contains a dif-
ferent set of case subjects, according to the GAW17
disease simulation. The average number of related cases is
21.72, with a range of 21–24 (p-values for excess disease
range from 0.002 to 0.007). Within each of these 18
extended high-risk pedigrees, there are 18 rare causal var-
iants that are polymorphic (from more than 100 causal
variants in the full disease model).
For each pedigree, we perform a genome-wide pSGS
analysis by examining the average sharing across all
pairs of case subjects. The test statistic for the pSGS
analysis (SH
case(k)) is similar to that previously proposed
by Nolte et al. [3] for a case-control haplotype-sharing





















where Rij is the run length, defined as the number of
SNPs in a row that are sharing IBS. Rij is obtained from
ap a i r w i s ec o m p a r i s o n between case subject i and case
subject j at locus k.
Statistical significance is determined using an empirical
approach based on a hidden Markov model. To ensure
that an appropriate linkage disequilibrium (LD) pattern is
preserved in the empirical approach, we estimate the LD
model using graphical models [4]. The genotypes of 78
independent individuals from the GAW17 family data,
including the 16 founders in the pedigree, are used for
LD model estimation. Subsequently, we use a gene-drop
program [5] to assign haplotypes to founders based on
the estimated LD model and to simulate genotypes for
descendants based on a genetic map according to the
known SNP base-pair position and the law of Mendelian
segregation, without regard to the disease status (i.e.,
under the null hypothesis H0). Using these simulated
genotype configurations, we calculate a null pSGS statis-
tic for each marker position in the genome. Significance
of each marker’s pSGS value is assessed against an
empirical distribution of at least 10,000 null test statistics
for that same position.
We use a significance threshold of a = 0.001 because
this level appears to differentiate peaks from background
signal. Pairwise shared genomic segments that reached the
significance threshold are identified, and true-positive and
false-positive rates are calculated based on the answers. A
true positive is defined as a region containing a causal
gene where the actual causal variant is polymorphic in the
pedigree cases. For each true positive, we summarize the
frequency of the causal variant in the pedigree case sub-
jects and compare it to the population frequency for the
variant.
Results
In 13 out of the 18 pedigree replicates (72.2%) we were
successful in identifying at least one region that contained
a true and polymorphic causal variant. Based on this
Figure 1 Pedigree structure. Case status shown for replicate 15.
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Replicate Chromosome p-value Causal gene Causal SNP Frequency in cases (%) Frequency in population (%) Run length range in causal gene
25 1 1 × 10
–4 PIK3C2B C1S9189 4.35 0.65 1,152.577–1,192.443
91 × 1 0
–5 VLDLR C9S444 17.39 0.14 793.933–802.051
27 9 1 × 10
–4 VLDLR C9S444 14.29 0.14 798.038–816.491
29 1 0.001 PIK3C2B C1S9189 4.76 0.65 1,065.976–1,106.357
4 0.001 VEGFC C4S4935 90.48 0.07 639.6238
91 × 1 0
–6 VLDLR C9S444 9.52 0.14 801.038–809.448
10 0.001 SIRT1 C10S3109 61.90 0.07 870.229–870.229
49 10 0.001 SIRT1 C10S3109 56.52 0.07 919.134–919.134
75 1 2 × 10
–4 PIK3C2B C1S9189 4.76 0.65 1,127.395–1,159.105
85 1 2 × 10
–4 PIK3C2B C1S9189 4.35 0.65 1,159.779–1,188.854
91 × 1 0
–4 VLDLR C9S444 13.04 0.14 764.763–770.269
94 1 1 × 10
–4 PIK3C2B C1S9189 4.76 0.55 1,232.038–1,256.771
116 9 4 × 10
–4 VLDLR C9S444 13.64 0.14 772.983–776.619
129 9 5 × 10
–4 VLDLR C9S444 20.83 0.14 712.761–728.337
142 9 9 × 10
–4 VLDLR C9S444 19.05 0.14 708.8238–711.8381
10 3 × 10
–4 SIRT1 C10S3109 57.14 0.07 863.629–863.629
184 9 7 × 10
–4 VLDLR C9S444 23.81 0.14 734.410–750.419
190 9 4 × 10
–5 VLDLR C9S444 18.18 0.14 779.281–782.654
199 10 6 × 10
–4 SIRT1 C10S3109 71.43 0.07 984.443–984.443





























































































5estimate, two pedigrees would gain more than 90% power
to identify a genomic region containing at least one true
causal locus. Using a significance threshold of 0.001 and
two high-risk pedigrees, one would expect to identify an
average of 5.5 regions including 2.1 true positives and 3.4
false positives.
Table 1 shows the true causal variants found in each
pedigree. Four (22%) out of the 18 rare causal variants that
were polymorphic in our selected pedigrees were identified
by the pSGS method. The most frequently identified cau-
sal variants were SNPs C9S444, which was found in 9 of
18 replicates (50%), C1S9189 (28%), and C10S2109 (22%).
Variant C4S4935 on chromosome 4 was found only once;
however, this variant was carried by more than 90% of the
case subjects in the pedigree, compared to a frequency of
less than 0.1% in the population (the largest discrepancy in
frequency identified). Five replicates identified no true
positives, nine replicates identified one, three replicates
identified two, and one pedigree identified four.
It is interesting to note that 10 out of 18 replicates identi-
fied the region on chromosome 19 (p ≤ 0 . 0 0 1 )t h a tc o n -
tains causal genes HIF3A and RRAS. However, the case
subjects in our pedigree replicates were not polymorphic
for the risk variants in these genes, and we classified this
finding as a false positive.
Discussion
We successfully localized four true-positive causal SNPs
from the 18 disease-susceptible SNPs that were poly-
morphic in our pedigree replicates. Additional genes,
such as VNN3 on chromosome 6, would have been iden-
tified at lower significance thresholds (p ≤ 0.01), but this
would also have increased false-positive findings. The
inability to detect the other rare variants may have sev-
eral explanations. First, we had a small sample size of
only 18 high-risk pedigree replicates, and our results may
not adequately reflect what can and cannot be identified.
Second, all GAW17 replicates were generated from the
same genotype data, and because selected replicates in
our study were all derived from the same structure, the
genotype data were consistent across all 18 replicates.
Even though the case status of individuals changed across
replicates, the underlying correlation may limit the scope
of which variants the pedigrees would have the power to
detect. Third, we restricted our pedigrees to be those
with a statistically significant excess of case subjects;
hence we may have also increased sporadic cases (hetero-
geneity). Finally, our pSGS statistic disregards the specific
relationships between each pair of case subjects, which
may not be optimal for power. To investigate this, we
considered a weighted mean based on the number of
meioses separating each pair. Some improvement was
observed, but it did not qualitatively alter the results here
(data not shown).
Conclusions
Identifying rare risk variants in common diseases is still a
challenge. We used the GAW17 mini-exome family data
set to investigate the utility of a novel pairwise SGS
method for detecting rare variants in a common trait
(about 30% prevalence). Our results, based on 18 extended
high-risk pedigree replicates, suggest that as few as two
pedigrees may offer greater than 90% power to detect at
least one true causal rare variant. Because few pedigrees
are needed and only case subjects are studied, the method
requires minimal genotyping or sequencing to achieve the
power and hence is cost-efficient.
It is important to balance power and false-positive find-
ings. Here we estimate a ratio of 1.1:1.7 true:false positive
findings per genome based on a significance threshold of
0.001. We believe that this is a reasonable ratio for a gene
discovery study. Nonetheless, exploring avenues to
increase power and reduce false positives is a useful endea-
vor. As mentioned, more sophisticated weighting statistics
may increase power. Alternative significance thresholds
may be superior for balancing the true and false positives.
For example, a threshold of 1 × 10
−5 would have resulted
in two true positives and one false positive across the 18
pedigree replicates (0.15:0.55 true:false positive findings
per genome); however, this more stringent threshold
would necessitate at least 14 pedigree replicates for at least
80% power. Finally, a requirement of matching the same
region across multiple pedigree replicates may also help
t h et r u e : f a l s er a t i o ,a l t h o u g ht h e s eG A W 1 7d a t aa r en o t
ideal for exploring such strategies because of the way the
data were generated and this also may not be fruitful if the
underlying risk variants are truly rare. In conclusion, our
new pairwise SGS method has demonstrated good poten-
tial for detecting rare variants in a common disease using
few high-risk pedigrees. Future work will involve addi-
tional steps to improve the method, in order to balance
true- and false-positive findings.
Acknowledgments
This research was supported in part by National Institutes of Health (NIH)
grant R01 GM81417 and Department of Defense (DOD) grant W81XWH-07-
01-0483 (awarded to AT) and by NIH grants R01 CA134674 and R21
CA152336 (awarded to NJC).
This article has been published as part of BMC Proceedings Volume 5 Supplement
9, 2011: Genetic Analysis Workshop 17. The full contents of the supplement are
available online at http://www.biomedcentral.com/1753-6561/5?issue=S9.
Author details
1Department of Biomedical Informatics, University of Utah, 391 Chipeta Way,
Salt Lake City, UT 84108, USA.
2Division of Genetic Epidemiology,
Department of Internal Medicine, University of Utah, 391 Chipeta Way, Salt
Lake City, UT 84108, USA.
Authors’ contributions
All authors contributed to the study design and approved the final
manuscript. SK carried out the quality control for the dataset. ZC performed
the statistical analysis. All authors participated in the drafting of the
manuscript.
Cai et al. BMC Proceedings 2011, 5(Suppl 9):S9
http://www.biomedcentral.com/1753-6561/5/S9/S9
Page 4 of 5Competing interests
The authors declare that there is no conflict of interests.
Published: 29 November 2011
References
1. Thomas A, Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA:
Shared genomic segment analysis: mapping disease predisposition
genes in extended pedigrees using SNP genotype assays. Ann Hum
Genet 2008, 72:279-287.
2. Leibon G, Rockmore DN, Pollak MR: A SNP streak model for the
identification of genetic regions identical-by-descent. Stat Appl Genet Mol
Biol 2008, 7:Article16, Doi: 10.2202/1544-6115.1340.
3. Nolte IM, de Vries AR, Spijker GT, Jansen RC, Brinza D, Zelikovsky A, Te
Meerman GJ: Association testing by haplotype-sharing methods
applicable to whole-genome analysis. BMC Proc 2007, 1(suppl 1):S129.
4. Thomas A: A method and program for estimating graphical models for
linkage disequilibrium that scale linearly with the number of loci, and
their application to gene drop simulation. Bioinformatics 2009,
25:1287-1292.
5. Thomas A: Assessment of SNP streak statistics using gene drop
simulation with linkage disequilibrium. Genet Epidemiol 2010, 34:119-124.
doi:10.1186/1753-6561-5-S9-S9
Cite this article as: Cai et al.: Pairwise shared genomic segment analysis
in high-risk pedigrees: application to Genetic Analysis Workshop 17
exome-sequencing SNP data. BMC Proceedings 2011 5(Suppl 9):S9.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Cai et al. BMC Proceedings 2011, 5(Suppl 9):S9
http://www.biomedcentral.com/1753-6561/5/S9/S9
Page 5 of 5